A Star Is Born? HERCULES Data Shine At ASH For Ablynx's Caplacizumab

SC1712_constellation Hercules_687159919_1200.jpg
Written in the stars: approvals expected in 2018 follwoing strong data for Ablynx's caplacizumab in HERCULES trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business